/pozdr
Odchudzanie w wieku dojrzewania
http://www.sfd.pl/temat548381 - Skalar
http://www.sfd.pl/temat549020 - Psonic
http://www.sfd.pl/temat549022 - Tancerka25
http://www.sfd.pl/Jajka__wiadomości_ogólne,_badania,_cholesterol.-t619144.html
/pozdr
Odchudzanie w wieku dojrzewania
http://www.sfd.pl/temat548381 - Skalar
http://www.sfd.pl/temat549020 - Psonic
http://www.sfd.pl/temat549022 - Tancerka25
http://www.sfd.pl/Jajka__wiadomości_ogólne,_badania,_cholesterol.-t619144.html
Lauric and palmitic acid-enriched diets have minimal impact on serum lipid and lipoprotein concentrations and glucose metabolism in healthy young women.
Fifteen healthy young women were fed diets enriched to 4% of energy with either palmitic acid (as palm oil) or lauric acid (as coconut oil). A randomized crossover study design was used so that subjects followed the two experimental diets for 4 wk, both preceded by consumption of a baseline diet for 2 wk. The experimental diets differed only with respect to the fatty acid composition: there was a substitution of 4% of energy intake with palmitic acid or lauric acid in the experimental diets for 4% of energy as monoenes in the baseline diet. There were no differences in the concentration of serum total or lipoprotein lipids, apolipoproteins A-I and B, and lipoprotein (a) or plasma cholesteryl ester transfer protein activity between the experimental diet periods. The VLDL cholesterol concentration (0.38 +/- 0.05 vs. 0.51 +/- 0.05 mmol/L, means +/- SEM, P = 0.01] and plasma cholesteryl ester transfer protein activity [78 +/- 5 vs. 88 +/- 6 mumol/(h.L), P = 0.007) were greater at the end of the lauric acid diet period than at the end of the preceding baseline diet period. No differences were found in glucose effectiveness, insulin sensitivity index or insulin secretion measured by the intravenous glucose tolerance test (Minimal Model method). In conclusion, in terms of serum lipids, lipoproteins, and glucose metabolism, palmitic acid was equal to lauric acid at 4% of total energy intake exchange, and both of these saturated fatty acids were comparable to a 4% of total energy intake exchange with monoenes in healthy young women.
http://www.ncbi.nlm.nih.gov/pubmed/7876922
nawet jakby jakis cudem konwertowal do epa/dha - to i tak brak wplywu na wrazliwosc insulinową! (bo o tym temat)
Zmieniony przez - solaros w dniu 2011-02-05 15:28:09
"Cóż jest trucizną?
Wszystko jest trucizną i nic nie jest trucizną, tylko dawka czyni, że dana substancja nie jest trucizną!".
BLOG: http://www.sfd.pl/t1033576.html
The available scientific evidence suggests that there are no significant long-term effects of fish oil in patients with diabetes.
Dostępne badania naukowe sugerują, że nie ma znaczących długoterminowych efektów stosowania oleju rybiego u pacjentów z cukrzycą.
Omega-3 jest skuteczne w:
High blood pressure
Multiple human trials report small reductions in blood pressure with intake of omega-3 fatty acid. DHA may have greater benefits than EPA. However, high intakes of omega-3 fatty acids per day may be necessary to obtain clinically relevant effects, and at this dose level, there is an increased risk of bleeding. Therefore, a qualified healthcare provider should be consulted prior to starting treatment with supplements.
Hypertriglyceridemia (fish oil / EPA plus DHA)
There is strong scientific evidence from human trials that omega-3 fatty acids from fish or fish oil supplements (EPA + DHA) significantly reduce blood triglyceride levels. Benefits appear to be dose-dependent. Fish oil supplements also appear to cause small improvements in high-density lipoprotein ("good cholesterol"); however, increases (worsening) in low-density lipoprotein levels (LDL/"bad cholesterol") are also observed. It is not clear if alpha-linolenic acid significantly affects triglyceride levels, and there is conflicting evidence in this area.The American Heart Association has published recommendations for EPA + DHA. Because of the risk of bleeding from omega-3 fatty acids, a qualified healthcare provider should be consulted prior to starting treatment with supplements.There is growing evidence that reducing C-Reactive Protein (CRP) is beneficial towards favorable cardiovascular outcomes, although additional research is pending in this area. The data on fish oils and CRP levels is mixed.
Secondary cardiovascular disease prevention (fish oil / EPA plus DHA)
Several well-conducted randomized controlled trials report that in people with a history of heart attack, regular consumption of oily fish or fish oil/omega-3 supplements reduces the risk of non-fatal heart attack, fatal heart attack, sudden death, and all-cause mortality (death due to any cause). Most patients in these studies were also using conventional heart drugs, suggesting that the benefits of fish oils may add to the effects of other therapies.
Primary cardiovascular disease prevention (fish intake)
Several large studies of populations ("epidemiologic" studies) report a significantly lower rate of death from heart disease in men and women who regularly eat fish. Other epidemiologic research reports no such benefits. It is not clear if reported benefits only occur in certain groups of people, such as those at risk of developing heart disease. Overall, the evidence suggests benefits of regular consumption of fish oil. However, well-designed randomized controlled trials which classify people by their risk of developing heart disease are necessary before a firm conclusion can be drawn.
Protection from cyclosporine toxicity in organ transplant patients
There are multiple studies of heart transplant and kidney transplant patients taking cyclosporine (Neoral®), who were administered fish oil supplements. The majority of trials report improvements in kidney function, and less high blood pressure compared to patients not taking fish oil. Although several recent studies report no benefits on kidney function, the weight of scientific evidence favors the beneficial effects of fish oil.
Rheumatoid arthritis (fish oil)
Multiple randomized controlled trials report improvements in morning stiffness and joint tenderness with the regular intake of fish oil supplements for up to three months. Benefits have been reported as additive with anti-inflammatory medications such as NSAIDs (like ibuprofen or aspirin). However, because of weaknesses in study designs and reporting, better research is necessary before a strong favorable recommendation can be made. Effects beyond three months of treatment have not been well evaluated.
Źródło: FDA – sorry, że tylko podsumowanie zamieściłem, ale badań klinicznych dokumentujących powyższe wskazania jest kilkaset…
Wydaje się najbardziej ekonomiczna forma o najlepszej przyswajalności bo do picia.
Möller's Tran Norweski 250ml cena w promocji 23zł
na 5 ml :
Kwasy tłuszczowe omega-3 1,2 g
- kwas eikozapentaenowy (EPA) 0,4 g
- kwas dokozaheksaenowy (DHA) 0,6 g
dodatkowo
Witamina E 10 mg (83% ZDS)
Witamina A 250 μg (31,25% ZDS)
Witamina D 10 μg (200% ZD)